{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T20:46:21Z","timestamp":1769805981202,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006260","name":"Technion - Israel Institute of Technology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006260","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction\/objective<\/jats:title>\n                    <jats:p>Giant Cell Arteritis (GCA) is relatively rare in the Middle East compared to Western countries. We aimed to retrospectively investigate the demographic, clinical, and imaging characteristics and the definitive diagnoses of patients referred to a GCA fast-track clinic (FTC) in the northwest of Israel with a mixed population of Arabs and Jews.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Demographic, clinical and laboratory data of patients referred to GCA-FTC between 2022 and 2024 were retrospectively collected. The Southend Pre-Test Probability Score for GCA (GCAPS) was calculated. Patients underwent color-Doppler ultrasound (CDUS) for the temporal and axillary arteries. The definitive diagnosis was determined by the treating rheumatologist based on clinical features, CDUS, additional imaging tests, and\/or biopsy results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seventy-two consecutive outpatients with a suspected diagnosis of GCA were included. The mean age was 74.6\u2009\u00b1\u20098.8years, 63% were females. Of these individuals, 19\/72 had a low GCAPS, of whom 2 were diagnosed with GCA; 40\/72 had an intermediate GCAPS, of whom 14 had a positive CDUS but only 9 had GCA diagnosis; and of 13 patients with high GCAPS, 10 were confirmed as having GCA by CDUS and one patient was diagnosed by computed tomography angiography (CTA). Large-vessel involvement was documented in only 2\/22 GCA patients. Among non-GCA patients, the most common diagnoses were pure polymyalgia rheumatica (PMR), migraine headache, infection, calcium-pyrophosphate deposition disease (CPPD), and temporomandibular joint (TMJ) dysfunction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The GCAPS is a reliable tool for risk-stratifying patients referred to the GCA-FTC in this study population. The sensitivity and specificity of CDUS was 90.9% and 88%, respectively. A relatively low prevalence of large vessel involvement was documented. Our results suggest that rheumatologists should remain vigilant regarding the differential diagnoses in patients with suspected GCA.<\/jats:p>\n                    <jats:p>\n                      <jats:table-wrap>\n                        <jats:table>\n                          <jats:tbody>\n                            <jats:tr>\n                              <jats:td align=\"left\" colspan=\"2\">\n                                <jats:bold>Key Points<\/jats:bold>\n                                \u2022\n                                <jats:italic>Our study is the first study in the Middle East to utilize color-Doppler ultrasonography (CDUS) in Giant Cell Arteritis Fast Track Clinic (GCA-FTC) setting, and it was found to have very high sensitivity (90.9) and specificity (88.0%).<\/jats:italic>\n                                \u2022\n                                <jats:italic>In our study population, the Southend Pre-Test Probability Score for GCA (GCAPS) was found to be a reliable tool for risk- stratifying patients referred to the GCA-FTC.<\/jats:italic>\n                                \u2022\n                                <jats:italic>Based on our findings, rheumatologists should remain vigilant regarding the differential diagnoses of patients with suspected GCA, including pure PMR, migraine headache, infection, CPPD and TMJ dysfunction.<\/jats:italic>\n                              <\/jats:td>\n                            <\/jats:tr>\n                          <\/jats:tbody>\n                        <\/jats:table>\n                      <\/jats:table-wrap>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10067-025-07787-0","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T07:45:27Z","timestamp":1764229527000},"page":"1181-1187","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient characteristics, disease manifestations and diagnostic findings of consecutive patients suspected of Giant Cell Arteritis (GCA) \u2014 retrospective experience from a fast-track clinic in Israel"],"prefix":"10.1007","volume":"45","author":[{"given":"Amir","family":"Haddad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8612-2698","authenticated-orcid":false,"given":"Tal","family":"Gazitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ameen","family":"Batheesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy","family":"Feld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi Yeshurun","family":"Finkelstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muna","family":"Elias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhanad Abu","family":"Elhija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noa","family":"Hayat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devy","family":"Zisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"7787_CR1","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3899\/jrheum.150557","volume":"43","author":"G Nesher","year":"2016","unstructured":"Nesher G, Ben-Chetrit E, Mazal B, Breuer GS (2016) The incidence of primary systemic vasculitis in Jerusalem: a 20-year hospital-based retrospective study. J Rheumatol 43:1072\u20131077. https:\/\/doi.org\/10.3899\/jrheum.150557","journal-title":"J Rheumatol"},{"key":"7787_CR2","first-page":"S15","volume":"25","author":"M Bas-Lando","year":"2007","unstructured":"Bas-Lando M, Breuer GS, Berkun Y et al (2007) The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations. Clin Exp Rheumatol 25:S15\u2013S17","journal-title":"Clin Exp Rheumatol"},{"key":"7787_CR3","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00296-024-05540-5","volume":"44","author":"F Alnaimat","year":"2024","unstructured":"Alnaimat F, Alduradi H, Al-Qasem S et al (2024) Giant cell arteritis: insights from a monocentric retrospective cohort study. Rheumatol Int 44:1013\u20131023. https:\/\/doi.org\/10.1007\/s00296-024-05540-5","journal-title":"Rheumatol Int"},{"key":"7787_CR4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1136\/bjo.2006.108845","volume":"91","author":"IA Chaudhry","year":"2007","unstructured":"Chaudhry IA, Shamsi FA, Elzaridi E et al (2007) Epidemiology of giant-cell arteritis in an Arab population: a 22-year study. Br J Ophthalmol 91:715\u2013718. https:\/\/doi.org\/10.1136\/bjo.2006.108845","journal-title":"Br J Ophthalmol"},{"key":"7787_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ejim.2008.07.030","volume":"20","author":"M Khalifa","year":"2009","unstructured":"Khalifa M, Karmani M, Jaafoura NG et al (2009) Epidemiological and clinical features of giant cell arteritis in Tunisia. Eur J Intern Med 20:208\u2013212. https:\/\/doi.org\/10.1016\/j.ejim.2008.07.030","journal-title":"Eur J Intern Med"},{"key":"7787_CR6","first-page":"830","volume":"27","author":"ON Pamuk","year":"2009","unstructured":"Pamuk ON, D\u00f6nmez S, Karahan B et al (2009) Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: clinical features and epidemiological data. Clin Exp Rheumatol 27:830\u2013833","journal-title":"Clin Exp Rheumatol"},{"key":"7787_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3899\/jrheum.140318","volume":"42","author":"E De Smit","year":"2015","unstructured":"De Smit E, Palmer AJ, Hewitt AW (2015) Projected worldwide disease burden from giant cell arteritis by 2050. J Rheumatol 42:119\u2013125. https:\/\/doi.org\/10.3899\/jrheum.140318","journal-title":"J Rheumatol"},{"key":"7787_CR8","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.semarthrit.2020.07.005","volume":"50","author":"A Sharma","year":"2020","unstructured":"Sharma A, Mohammad AJ, Turesson C (2020) Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: a systematic literature review. Semin Arthritis Rheum 50:1040\u20131048. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.07.005","journal-title":"Semin Arthritis Rheum"},{"key":"7787_CR9","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1136\/ard-2023-224543","volume":"83","author":"C Dejaco","year":"2024","unstructured":"Dejaco C, Ramiro S, Bond M et al (2024) EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update. Ann Rheum Dis 83:741\u2013751. https:\/\/doi.org\/10.1136\/ard-2023-224543","journal-title":"Ann Rheum Dis"},{"key":"7787_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003379","author":"P Bosch","year":"2023","unstructured":"Bosch P, Bond M, Dejaco C et al (2023) Imaging in diagnosis, monitoring and outcome prediction of large vessel vasculitis: a systematic literature review and meta-analysis informing the 2023 update of the EULAR recommendations. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2023-003379","journal-title":"RMD Open"},{"key":"7787_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.589794","volume":"7","author":"S Monti","year":"2020","unstructured":"Monti S, Bartoletti A, Bellis E et al (2020) Fast-track ultrasound clinic for the diagnosis of giant cell arteritis changes the prognosis of the disease but not the risk of future relapse. Front Med 7:589794. https:\/\/doi.org\/10.3389\/fmed.2020.589794","journal-title":"Front Med"},{"key":"7787_CR12","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1136\/annrheumdis-2021-220306","volume":"80","author":"C Ponte","year":"2021","unstructured":"Ponte C, Monti S, Scir\u00e8 CA et al (2021) Ultrasound halo sign as a potential monitoring tool for patients with giant cell arteritis: a prospective analysis. Ann Rheum Dis 80:1475\u20131482. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220306","journal-title":"Ann Rheum Dis"},{"key":"7787_CR13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/art.41165","volume":"72","author":"KB Gribbons","year":"2020","unstructured":"Gribbons KB, Ponte C, Craven A et al (2020) Diagnostic assessment strategies and disease subsets in giant cell arteritis: data from an international observational cohort. Arthritis Rheumatol 72:667\u2013676. https:\/\/doi.org\/10.1002\/art.41165","journal-title":"Arthritis Rheumatol"},{"issue":"Suppl 117","key":"7787_CR14","first-page":"104","volume":"37","author":"F Laskou","year":"2019","unstructured":"Laskou F, Coath F, Mackie SL et al (2019) A probability score to aid the diagnosis of suspected giant cell arteritis. Clin Exp Rheumatol 37(Suppl 117):104\u2013108","journal-title":"Clin Exp Rheumatol"},{"key":"7787_CR15","doi-asserted-by":"publisher","first-page":"rkab102","DOI":"10.1093\/rap\/rkab102","volume":"6","author":"AR Melville","year":"2022","unstructured":"Melville AR, Donaldson K, Dale J, Ciechomska A (2022) Validation of the Southend giant cell arteritis probability score in a Scottish single-centre fast-track pathway. Rheumatol Adv Pract 6:rkab102. https:\/\/doi.org\/10.1093\/rap\/rkab102","journal-title":"Rheumatol Adv Pract"},{"key":"7787_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2023.101847","volume":"37","author":"WA Schmidt","year":"2023","unstructured":"Schmidt WA (2023) Vascular ultrasound in rheumatology practice. Best Pract Res Clin Rheumatol 37:101847. https:\/\/doi.org\/10.1016\/j.berh.2023.101847","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"7787_CR17","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1136\/ard-2022-223480","volume":"81","author":"C Ponte","year":"2022","unstructured":"Ponte C, Grayson PC, Robson JC et al (2022) 2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis. Ann Rheum Dis 81:1647\u20131653. https:\/\/doi.org\/10.1136\/ard-2022-223480","journal-title":"Ann Rheum Dis"},{"key":"7787_CR18","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1016\/S2665-9913(24)00027-4","volume":"6","author":"A Sebastian","year":"2024","unstructured":"Sebastian A, van der Geest KSM, Tomelleri A et al (2024) Development of a diagnostic prediction model for giant cell arteritis by sequential application of Southend Giant Cell Arteritis Probability Score and ultrasonography: a prospective multicentre study. Lancet Rheumatol 6:e291\u2013e299. https:\/\/doi.org\/10.1016\/S2665-9913(24)00027-4","journal-title":"Lancet Rheumatol"},{"key":"7787_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000598","volume":"4","author":"S Chrysidis","year":"2018","unstructured":"Chrysidis S, Duftner C, Dejaco C et al (2018) Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT Large Vessel Vasculitis Ultrasound Working Group. RMD Open 4:e000598. https:\/\/doi.org\/10.1136\/rmdopen-2017-000598","journal-title":"RMD Open"},{"key":"7787_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-004667","author":"C Duftner","year":"2025","unstructured":"Duftner C, Redlinger N, Bruyn GA et al (2025) Reliability of the OMERACT giant cell arteritis ultrasonography score (OGUS): results of a patient-based exercise involving experts and non-experts in vascular ultrasonography. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2024-004667","journal-title":"RMD Open"},{"key":"7787_CR21","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/rheumatology\/kead189","volume":"63","author":"E De Miguel","year":"2024","unstructured":"De Miguel E, Macchioni P, Conticini E et al (2024) Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica. Rheumatology (Oxford) 63:158\u2013164. https:\/\/doi.org\/10.1093\/rheumatology\/kead189","journal-title":"Rheumatology (Oxford)"},{"key":"7787_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.152069","volume":"56","author":"AW Nielsen","year":"2022","unstructured":"Nielsen AW, Fr\u00f8lund LL, V\u00e5ben C et al (2022) Concurrent baseline diagnosis of giant cell arteritis and polymyalgia rheumatica - a systematic review and meta-analysis. Semin Arthritis Rheum 56:152069. https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152069","journal-title":"Semin Arthritis Rheum"},{"key":"7787_CR23","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X241251742","volume":"16","author":"WA Schmidt","year":"2024","unstructured":"Schmidt WA, Sch\u00e4fer VS (2024) Diagnosing vasculitis with ultrasound: findings and pitfalls. Ther Adv Musculoskelet Dis 16:1759720X241251742. https:\/\/doi.org\/10.1177\/1759720X241251742","journal-title":"Ther Adv Musculoskelet Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07787-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07787-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07787-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:02:31Z","timestamp":1769763751000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07787-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7787"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07787-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the principles of the Declaration of Helsinki and was approved by the research ethics committees (institutional review board) of Carmel Medical Center (CMC-0135\u201324). Requirement for individual patient consent forms was waived due to the retrospective, observational nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors reviewed the manuscript, helped in editing it, and approved of its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}